Medical Imaging Corporation (6637) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Medical Imaging Corporation stock TWD 129, price TWD 51.70, upside +149.7%, quality 34 out of 100. Rating: strongly undervalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 29.14 TWD – 126.77 TWD · fair‑value band 56.53 TWD – 175.86 TWD · the 51.70 TWD price screens below the 129.08 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow Medical Imaging in your weekly email
Every Wednesday you see whether Medical Imaging is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Medical Imaging Corporation offers imaging hospital equipment leasing and maintenance services in China. The company's products include ultrasound sonography, bone densitometer, emergency rooms and intensive isolation wards, and radiation protection lead plates.
Show moreShow less
It also distributes medical equipment and drugs; and engages in the wholesale and retail of pharmaceuticals and medical equipment, as well as international trade and management consulting activities. The company was founded in 1992 and is based in Taipei, Taiwan.
Stock analysis
Medical Imaging Corporation (6637) currently trades at 51.70 TWD, while our model-based Fair Value estimate is 129.08 TWD, implying the stock looks roughly 60% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 298.82 TWD per share, and 16 of the 17 models we run sit above the 51.70 TWD price.
Bear case: the Asset-Based group reads lowest at 14.57 TWD, and 1 of the 17 models stay below the price. Data coverage for this calculation is high.
Scenario range: 56.53 TWD (bear) to 175.86 TWD (bull), the price of 51.70 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Medical Imaging Corporation reported revenue of 1.2B TWD in FY2025 versus 604M TWD in FY2021, a compound +17.8%/yr. Reported net income was 186M TWD in FY2025, compounding +24.7%/yr from FY2021.
Key figures
Market cap 1.4B TWD (≈ $42.2M) Micro · P/E ratio 9.5 · P/S ratio 1.51 · EPS (TTM) 5.46 TWD · Dividend yield 8.7% · Net margin 16.1% · Return on equity 14.0% · Return on assets (EBIT) 17.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 59 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 34% fair-value upside, at 150%, 6637 screens cheaper than that median.
Fair Value models
Bear56.53 TWDFair Value 129.08 TWDBull175.86 TWD
Price 51.70 TWD · Upside +149.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.8232 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+40.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+33.7%
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+23.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+14.5%
Dividend (yield on the price)8.7%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22% → 19%
Compare Medical Imaging Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 76 stocks
Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score34 · Bottom 25%
Fair Value upside+149.7% · Top 25%
Profitability
Return on equity (12 months)14.0% · Top 25%
Return on assets9.7% · Top 25%
Net margin (12 months)16.1% · Top 25%
Operating margin (12 months)15.8% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)−48.6% · Bottom 25%
Dividend yield (12 months)8.7% · Top 25%
Balance sheet
Debt / equity0.34× · Highest 25%
Valuation Multiplesvs Medical Distribution median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Medical Imaging Corporation (6637) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 129.08 TWD versus a price of 51.70 TWD, about +150% upside (undervalued).
What is the fair value of 6637?
Our model-based fair value for Medical Imaging Corporation is 129.08 TWD (as of Nov 9, 2026), built from audited fundamentals. The current price: 51.70 TWD.
What is the quality score of 6637?
Medical Imaging Corporation has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Medical Imaging Corporation (6637)?
Our model-based price target is the fair value of 129.08 TWD (as of Nov 9, 2026) from 17 valuation models. Cautious scenario 56.53 TWD, optimistic scenario 175.86 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Medical Imaging Corporation stock forecast for 2026?
Our models put fair value at 129.08 TWD, about +150% upside versus a price of 51.70 TWD (undervalued). Cautious scenario 56.53 TWD, optimistic scenario 175.86 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Medical Imaging Corporation (6637)?
Medical Imaging Corporation reported trailing-twelve-month revenue of about 915M TWD (latest available figure, as of Nov 9, 2026).
Does Medical Imaging Corporation pay a dividend?
Medical Imaging Corporation currently shows a dividend yield of 8.70% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Medical Imaging Corporation (6637) and when is the ex-dividend date?
Medical Imaging Corporation pays a dividend of 4.50 TWD per share a year, a dividend yield of 8.7%. The last ex-dividend date was Aug 27, 2026. A dividend has been paid every year since at least 2017. The payout ratio is 82.4% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Medical Imaging Corporation (6637)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Medical Imaging Corporation it is 129.08 TWD per share (as of Nov 9, 2026), against a price of 51.70 TWD. It is the blended result of 17 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Medical Imaging Corporation stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 6637 trades below its calculated fair value: price 51.70 TWD, fair value 129.08 TWD, a gap of about +150% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6637?
No. The price is what the market pays today (51.70 TWD); the fair value is what the company's own numbers justify (129.08 TWD). For Medical Imaging Corporation the two are 77.38 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Medical Imaging Corporation worth?
The market values Medical Imaging Corporation at about 1.4B TWD (market capitalisation, as of Nov 9, 2026). Per share that is 51.70 TWD; our models calculate a fair value of 129.08 TWD per share.
What do the bullish and bearish scenarios say about 6637?
Our models span a range for Medical Imaging Corporation: cautious scenario 56.53 TWD, base 129.08 TWD, optimistic 175.86 TWD per share (as of Nov 9, 2026, price 51.70 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6637?
Medical Imaging Corporation trades at a price-to-earnings ratio of 9.5 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 129.08 TWD is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2021 to 2025), reported earnings: 11.7. Other multiples: P/B 1.2, P/S 1.5, EV/EBITDA 6.1.
How solid is the balance sheet of Medical Imaging Corporation (6637)?
Balance-sheet figures for Medical Imaging Corporation (as of Nov 9, 2026): return on equity 14.0%, debt of 0.34 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is 6637 from its 52-week high?
Medical Imaging Corporation trades at 51.70 TWD, about 33% below its 52-week high of 76.86 TWD and 1% above the low of 51.30 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 129.08 TWD is for.
Which stocks are comparable to Medical Imaging Corporation?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Medical Imaging Corporation stock attractive at the current price?
The data as of Nov 9, 2026: price 51.70 TWD, calculated fair value 129.08 TWD (+150%), Quality Score 34/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6637 calculated?
We run Medical Imaging Corporation through 17 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 129.08 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Medical Imaging Corporation currently trades 60% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Medical Imaging Corporation (6637)?
The closing price on Nov 9, 2026 was 51.70 TWD. Our model-based fair value is 129.08 TWD, about +150% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Medical Imaging Corporation right now?
The large discount to fair value meets weak quality (34/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (56.53 TWD). The market is more pessimistic than our downside scenario. The model range is unusually wide (56.53 TWD to 175.86 TWD). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Key figures of Medical Imaging Corporation
How large is the market capitalisation of Medical Imaging Corporation (6637)?
The market capitalisation of Medical Imaging Corporation is 1.4B TWD (≈ $42.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Medical Imaging Corporation (6637)?
The price-to-sales ratio of Medical Imaging Corporation is 1.51 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Medical Imaging Corporation (6637)?
Earnings per share at Medical Imaging Corporation are 5.46 TWD (price ÷ EPS = P/E 9.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Medical Imaging Corporation (6637)?
The dividend yield of Medical Imaging Corporation is 8.7% (payout 82.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Medical Imaging Corporation (6637)?
The net margin of Medical Imaging Corporation is 16.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Medical Imaging Corporation (6637)?
The return on equity (ROE) of Medical Imaging Corporation is 14.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Medical Imaging Corporation (6637)?
On an EBIT basis the return on assets of Medical Imaging Corporation is 17.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Medical Imaging Corporation (6637)?
The operating margin of Medical Imaging Corporation is 15.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Medical Imaging Corporation (6637)?
Revenue at Medical Imaging Corporation is growing −48.6% versus a year earlier (3y avg +33.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Medical Imaging Corporation (6637)?
Earnings per share at Medical Imaging Corporation are growing −46.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Medical Imaging Corporation (6637) generate?
The free cash flow of Medical Imaging Corporation is −322M TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Medical Imaging Corporation (6637) carry?
The net debt of Medical Imaging Corporation is 85.9M TWD (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Medical Imaging Corporation in the live analysis
One click puts Medical Imaging Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 9, 2026